<DOC>
	<DOCNO>NCT00781794</DOCNO>
	<brief_summary>The purpose study evaluate effect single dose NSA-789 P50 component auditory evoke potential assess safety , tolerability concentration NSA-789 blood , nonsmoking patient schizophrenia .</brief_summary>
	<brief_title>Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Inclusion criterion : Women nonchildbearing potential , men , age 18 55 year inclusive study day 1 . Women nonchildbearing potential may include either surgically sterile ( hysterectomy and/or oophorectomy ) postmenopausal â‰¥1 year ( folliclestimulating hormone [ FSH ] level â‰¥38 mIU/mL ) . Women surgically sterile must provide documentation procedure operative report ultrasound scan . Sexually active men must agree use medically acceptable form contraception study continue 12 week test article administration . Body mass index range 18 32 kg/m2 body weight â‰¥50 kg . Hemoglobin low 0.4 g/dL , less low limit normal range , white blood cell count low 0.5 103/mm3 , less low limit normal range screen day 1 . Hematocrit absolute neutrophil count within normal range screen day 1 . Exclusion criterion : Women childbearing potential . Presence history disorder may prevent successful completion study . Any unstable psychiatric condition , may prevent successful safe completion study opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>